期刊文献+

长期右心室起搏出现心力衰竭的患者升级三腔起搏对心功能的影响探讨 被引量:5

Preliminary Investigation for Dual-Chamber Pacemaker Upgraded to Three-Chamber Pacing in Treating the Patients With Long Term Right Ventricular Pacing Appearing Heart Failure
下载PDF
导出
摘要 目的:针对长期右心室心尖起搏后出现心力衰竭的患者,观察采用双腔起搏器升级三腔起搏治疗心力衰竭的临床疗效。方法:10例植入永久双腔起搏器后出现心力衰竭的患者,术中保留原心房和右心室心尖部永久起搏导管,并经左锁骨下静脉植入左心室永久起搏导管至左心室侧静脉或侧后静脉起搏左心室。观察三腔起搏术后0.5、1、2、3年10例患者纽约心脏协会(NYHA)心功能分级、六分钟步行试验、左心室舒张末径、左心室射血分数的变化。结果:三腔起搏术后0.5、1、2、3年的随访,10例患者无死亡发生,因心力衰竭住院次数明显减少、NYHA心功能分级长期维持在II^III级、六分钟步行试验显著延长、左心室舒张末径减小、左心室射血分数增加。结论:长期右心室心尖起搏后出现心力衰竭的患者,双腔起搏器升级三腔起搏可改善患者的左心功能。 Objective: To explore the effect of dual-chamber pacemaker upgraded to three-chamber pacing in treating the patients with long term right ventricular pacing appearing heart failure (HF). Methods: We studied 10 patients who received dual-chamber pacemaker implantation appearing HF, those patients were treated with upgraded biventricular three-chamber pacing by reserving the original atrium and right ventricular apical pacemaker catheter, then implanting left ventricular pacing catheter via left sub-clavian vein or left posterior vein to pacing left ventricle. We observed the post procedural HF caused hospitalization per year, NYHA classification, 6-minute walking test, left ventricular end-diastolic diameter (LVEDD) and left ventricular ejection fraction (LVEF) for 0.5, 1, 2 and 3 years in all 10 patients. Results: During 3 years follow-up period, the patients presented obviously less HF caused hospitalization, NYHA classification maintained at Ⅱ~Ⅲ for long term, significantly increased 6-minute walking distance, decreased LVEDD and increased LVEF. Conclusion: In patients with long term right ventricular apical pacing appearing HF, upgrading from dual-chamber pacemaker to biventricular three-chamber pacing could improve the patients' left cardiac function.
出处 《中国循环杂志》 CSCD 北大核心 2013年第5期338-341,共4页 Chinese Circulation Journal
关键词 心力衰竭 双腔起搏 升级的三腔起搏 Heart failure Dual-chamber pacing Upgraded three-chamber pacing
  • 相关文献

参考文献7

  • 1Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused update of ESC guidelines on device therapy in heart failure. An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chrnic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J, 2010, 31: 2677-2687.
  • 2Irene E, Kevin V, Tammo D, et al. Beneficial effects of biventricular pacing in chronically right ventricular paced patients with mild cardiomyopathy. Europace, 2010, 12: 223-229.
  • 3Georg F, Jan S, David H, et al. Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodeling. Eur Heart J, 2010, 31: 1477-1485.
  • 4Tops LF, Schalij MJ, Holman ER, et al. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coli Cardiol, 2006, 48: 1642- 1648.
  • 5Thambo JB, Bordachar P, Garrigue S, et al. Detrimental ventricular remodeling in patients witb congenital complete heart block and chronic right ventricular apical pacing. Circulation, 2004, 110: 3766- 3772.
  • 6杨立波,张华,贾绍斌.具有一键优化功能的起搏器心脏再同步化治疗慢性心力衰竭的临床观察[J].中国循环杂志,2011,26(2):121-124. 被引量:8
  • 7吴学思.心力衰竭的进展(17)B型利钠肽在心力衰竭诊断和治疗中的应用(续12)[J].中国循环杂志,2007,22(5):323-325. 被引量:13

二级参考文献23

  • 1Varma C, Camm AJ. Paee for heart failure, Lamcet,2001 357 (9264) : 1277-1283.
  • 2Cazcau S, Leclercq C, Lavergne T, et al. For the Mult~site Stimulation io Cardiomyopathies (MUSTIC) study investigator. Effect of multisite biventricular pacing in patients with heart failure and intraventricutar conduction delay. N Engl J Med,2001,344(12) :873-880.
  • 3Abraham WT, Fisher WG, Smith AL, et al. MIRACI,E Study Group. Multicenter In Syne randomized clinical evaluation. Cardiac resynehron ization in chrome heart failare. N Engl J Med,2002,346 (24) : 1845-.
  • 4Bristow MR, Saxen LA Boehmet J, et al. Comparison of Medical Therapy, Pacing and Defibrillation in heart failure (COMPANTION) Investigators. Cardiae-resynehronization lherapy with or without an implantable defibrillation in advanced chronic heart failure. N Engl J Med, 2004,350(21 ) :2140-2150.
  • 5Cieland JG, Daubert JC, Erdmann E, et al. The Cardiac resynehronization in heart failure(CARE-HF) Study Investigator. The effect of cardiac resynchronization on mortality in heart failure. N Engl J Med ,2005, 352 (15) : 1539-1549.
  • 6Auricchio A,Stellbrink C,Sack S,et al. The pacing therapies for congestive heart failure (PATH-CHF) study rationale, design, and endpoints of a prospective randomized multicenter study. Am J Cardiol, 1999,83 (5B) :130D-135D.
  • 7Cleland JG, Daubert JC, Erdmann E, ct al. The effect of cardiac resynchronization on mortality in heart failure. N Engl J Med,2005,352-415) : 1539-1549.
  • 8Reumem M, Farina D, Miri R, ct al. Computer model for the optimizatior, of AV andiron delay in cardiac resynchronization therapy. Med Boil Eng Compul ,2017,4 (9) :845-854.
  • 9Baker JH, McKenzie J, Beau S, et al. Acute evaluation of programmer guided AV/PV and VV delay optimization comparing an IEGM method and cchoeandiogram for cardiac resynchronization therapy in heart failure patients and dual-chamber ICD implants. J Cardiovasc Electrophy,physiology,2007,18 ( 2 ) : 185-191.
  • 10Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of Btype natriuretic peptide in the emergency diagnosis of heart failure.N Engl J Med,2002,347(3):161-167.

共引文献19

同被引文献40

  • 1Fabbian F, l)e (;iorgi A, Pala M, et al. Predictive value of admission N-terminal pro-B-type nalriuretie peptide and renal function in .lderpeople hospitalized for dyspnoea. Dis Markers, 2013, 35: 735-740.
  • 2Robier C, Neubauer M, Binter G, et al. Extensive elevation of BNP but not NT-ProBNP in a patient with advanced urothelial carcinoma in absence of cardiac failure and volume overload.Clin Chem Lab Med, 2014,52:e99-e101.
  • 3European Study Group on Diastolic Heart Failure. Working group report: how to diagnose heart failure. Eur Heart J, 1998, 19: 990-1003.
  • 4Menting ME, Eindhoven JA, van den Bosch AE, et al. Abnormal left ventrlcular rotatitm and twist in aduh patients with corrected tetralogy of Fallot. Eur Heart J Cardiovasc Imaging, 2014, 15: 566-574.
  • 5Humm K, Hezzell M, Sargent J, et al. Differentiating between feline plearal effusions of cardiac and non-cardiac origin using pleural fluid NT-proBNP concentrations. J Small Anita Pratt, 2013,54: 656-661.
  • 6Obaid FA, Maskon O, Abdolwahid F, et al. Systolic Function and Intraventricular Mechanical yssynchrony Assessed by Advanced Speekle Tracking hnaging with N-terminal Prohormone of Brain Natriurelic Peptide for Outcome Prediction in Chronic Heart Failure Patients. Sultan Qaboos Univ Med J, 2013, 13: 551-559.
  • 7Martins T, Vitorino R, Moreira-Gonqalves D, et al. Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia. Clin Biochem, 2014, 47: 8-15.
  • 8Toff WD, Carom AJ, Skehan JD, et al. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block[J]. N Engl J Med, 2005,353(2) : 145-155.
  • 9Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators[J]. N Engl J Med, 2000,342 (19) : 1385- 1391.
  • 10Sweency MO, Hellkamp AS. Heart failure during cardiac pacing[J]. Circulation, 2006,113 (17) : 2082-2088.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部